Selected article for: "acute cardiac failure and lung injury"
Author: Lumbers, Eugenie R.; Delforce, Sarah J.; Pringle, Kirsty G.; Smith, Gary R.
Title: The Lung, the Heart, the Novel Coronavirus, and the Renin-Angiotensin System; The Need for Clinical Trials
  • Cord-id: tj7z3ocr
  • Document date: 2020_5_22
    • ID: tj7z3ocr
    Snippet: Angiotensin-converting enzyme 2 (ACE2) is the receptor for COVID-19 (SARs-CoV-2). ACE2 protects the lung and heart from acute respiratory distress syndrome (ARDS) and acute myocarditis and arrhythmias, because it breaks down Angiotensin II, which has inflammatory effects in the lung and heart as well as in the kidney. When SARS-CoV-2 binds to ACE2, it suppresses it, so this protective action of ACE2 is lost. Death from COVID-19 is due to ARDS and also heart failure and acute cardiac injury. Drug
    Document: Angiotensin-converting enzyme 2 (ACE2) is the receptor for COVID-19 (SARs-CoV-2). ACE2 protects the lung and heart from acute respiratory distress syndrome (ARDS) and acute myocarditis and arrhythmias, because it breaks down Angiotensin II, which has inflammatory effects in the lung and heart as well as in the kidney. When SARS-CoV-2 binds to ACE2, it suppresses it, so this protective action of ACE2 is lost. Death from COVID-19 is due to ARDS and also heart failure and acute cardiac injury. Drugs that prevent the inflammatory actions of Angiotensin II (i.e., Angiotensin receptor blockers, ARBs) prevent acute lung injury caused by SARS-CoV. Clinical trials are underway to test the risks and benefits of ARBs and angiotensin-converting enzyme inhibitors (ACEIs) in COVID-19 patients requiring hospitalization. Other potential treatments are also discussed.

    Search related documents:
    Co phrase search for related documents
    • ace activity and active peptide: 1
    • ace activity and activity affect: 1, 2
    • ace activity and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8
    • ace activity and acute cardiac injury: 1
    • ace activity and acute lung: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • ace activity and acute lung injury: 1, 2, 3, 4, 5, 6, 7, 8
    • ace activity and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ace activity and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • ace activity and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • ace activity and lung heart: 1, 2, 3, 4
    • ace activity and lung inflammation: 1
    • ace activity and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • ace activity and lung protect: 1
    • ace activity inhibit and acute respiratory: 1
    • ace activity inhibit and acute respiratory syndrome: 1
    • ace activity inhibit and acute sars cov respiratory syndrome coronavirus: 1
    • ace enzyme and acid aspiration: 1
    • ace enzyme and active peptide: 1, 2
    • ace enzyme and activity affect: 1, 2